Computational Tool for Fast in silico Evaluation of hERG K(+) Channel Affinity

Frontiers in Chemistry
Giulia ChemiMargherita Brindisi

Abstract

The development of a novel comprehensive approach for the prediction of hERG activity is herein presented. Software Phase has been used to derive a 3D-QSAR model, employing as alignment rule a common pharmacophore built on a subset of 22 highly active compounds (threshold Ki: 50 nM) against hERG K(+) channel. Five features comprised the pharmacophore: two aromatic rings (R1 and R2), one hydrogen-bond acceptor (A), one hydrophobic site (H), and one positive ionizable function (P). The sequential 3D-QSAR model developed with a set of 421 compounds (randomly divided in training and test set) yielded a test set (Q(2)) = 0.802 and proved to be predictive with respect to an external test set of 309 compounds that were not used to generate the model ([Formula: see text] = 0.860). Furthermore, the model was submitted to an in silico validation for assessing the reliability of the approach, by applying a decoys set, evaluating the Güner and Henry score (GH) and the Enrichment Factor (EF), and by using the ROC curve analysis. The outcome demonstrated the high predictive power of the inclusive 3D-QSAR model developed for the hERG K(+) channel blockers, confirming the fundamental validity of the chosen approach for obtaining a fast proprie...Continue Reading

References

Jul 3, 1999·BMJ : British Medical Journal·S Gottlieb
Nov 8, 2001·European Journal of Pharmacology·K FinlaysonJ S Kelly
Jan 11, 2002·Journal of Medicinal Chemistry·Stephen R FletcherAngus M MacLeod
Jun 21, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·Jean T BarbeyDouglas P Zipes
Jun 6, 2003·British Journal of Pharmacology·Dierk ThomasChristoph A Karle
Jul 23, 2003·Bioorganic & Medicinal Chemistry Letters·György M Keserü
Mar 5, 2004·The New England Journal of Medicine·Dan M Roden
Sep 10, 2004·The New England Journal of Medicine·Wayne A RayC Michael Stein
Jan 8, 2005·European Heart Journal·M L De BruinH G M Leufkens
Feb 19, 2005·Drug Discovery Today·Alex M Aronov
Dec 6, 2005·Journal of Pharmacological and Toxicological Methods·Steven M MurphyAlain Stricker-Krongrad
Jan 18, 2006·Bioorganic & Medicinal Chemistry·Ramy FaridRobert A Pearlstein
Mar 10, 2006·Bioorganic & Medicinal Chemistry Letters·Christopher BlackburnPhilip R Kym
Mar 24, 2006·Nature·Michael C Sanguinetti, Martin Tristani-Firouzi
Aug 26, 2006·Bioorganic & Medicinal Chemistry Letters·Bing-Yan ZhuYonghong Song
Dec 5, 2006·Journal of Pharmacological and Toxicological Methods·Matt DeaconChristine Williams
Dec 13, 2006·Journal of Medicinal Chemistry·Niu HuangJohn J Irwin
Oct 11, 2007·Journal of Computational Chemistry·Matteo MasettiMaurizio Recanatini
Feb 24, 2009·Bioorganic & Medicinal Chemistry Letters·Dafydd R OwenBlanda L C Stammen
May 14, 2009·Bioorganic & Medicinal Chemistry Letters·Snahel D PatelNatasha M Kablaoui
Jun 26, 2009·Bioorganic & Medicinal Chemistry Letters·Timothy CoonGraham Beaton
Jul 22, 2009·BMC Bioinformatics·Wei ZhaoJames M Boyett
May 12, 2010·Bioorganic & Medicinal Chemistry Letters·Huaqing LiuMarlon D Cowart
Mar 8, 2011·European Journal of Medicinal Chemistry·Sundarapandian ThangapandianKeun Woo Lee
Mar 25, 2011·Bioorganic & Medicinal Chemistry Letters·Renee AspiotisTom Wu
May 3, 2011·European Journal of Medicinal Chemistry·Sugunadevi SakkiahKeun Woo Lee
Aug 2, 2011·Bioorganic & Medicinal Chemistry Letters·Nicolas LevoinMarc Capet
Dec 2, 2011·The Journal of Pharmacology and Experimental Therapeutics·M Paola CastelliFederico Corelli
Jun 22, 2012·Journal of Medicinal Chemistry·Michael M MysingerBrian K Shoichet
Sep 20, 2012·Journal of Chemical Information and Modeling·Serdar DurdagiSergei Y Noskov
May 9, 2013·Current Topics in Medicinal Chemistry·Rodolpho C Braga, Carolina H Andrade
May 17, 2013·Current Topics in Medicinal Chemistry·Sichao WangTingjun Hou
Jul 25, 2013·European Journal of Medicinal Chemistry·Simone BrogiAndrea Tafi
Mar 7, 2014·Journal of Chemical Information and Modeling·Shagun KrishnaDibyendu Banerjee
Oct 3, 2015·Bioorganic & Medicinal Chemistry Letters·Simone BrogiStefania Butini

❮ Previous
Next ❯

Citations

Feb 22, 2018·Molecular Informatics·Daniel Șterbuleac, Călin Lucian Maniu
May 30, 2019·BMC Bioinformatics·Hyang-Mi LeeDokyun Na
Aug 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Simone Brogi
Apr 26, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hajar SirousGiulia Chemi
Sep 4, 2019·PloS One·Bryan CernudaZafir Buraei
Feb 23, 2018·Frontiers in Pharmacology·Rodolfo S SimõesKathia M Honorio
Oct 8, 2019·Antioxidants & Redox Signaling·Alma MartelliVincenzo Calderone
Apr 28, 2019·International Journal of Molecular Sciences·Alessandro PedrettiGiulio Vistoli
Nov 6, 2020·Methods and Protocols·Valentina CitiVincenzo Calderone
Nov 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Edson Roberto da SilvaClaudia do Carmo Maquiaveli
Mar 2, 2021·Experimental Biology and Medicine·Siyu ZhuJing An
Feb 18, 2021·ChemMedChem·Marisa G Santibáñez-Morán, José L Medina-Franco
Apr 24, 2021·ACS Chemical Neuroscience·Alessandro GrilloGiuseppe Di Giovanni
Dec 2, 2020·Journal of Chemical Information and Modeling·Vishal B SiramshettyAlexey V Zakharov
Feb 5, 2019·Journal of Chemical Information and Modeling·Chuipu CaiFeixiong Cheng
Dec 1, 2018·Journal of Chemical Information and Modeling·Youyi PengWilliam J Welsh
Sep 24, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Tebyan O MirganyHuda S Al-Salem

❮ Previous
Next ❯

Software Mentioned

Maestro
GiCa
Phase
DUD
Enrichment Calculator
LigPrep
Database of Useful Decoys : Enhanced ( DUD - E )
Maestro suite
py
MacroModel

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.